Product
AUR103
Aliases
AUR 103 Calcium
1 clinical trial
5 indications
Indication
Solid TumorIndication
AdultIndication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromesIndication
Non-Hodgkin LymphomaClinical trial
A Phase I, Open Label, Dose-Escalation, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AUR103 Calcium in Patients With Relapsed Advanced Malignancies( BHARAT-1)Status: Recruiting, Estimated PCD: 2025-09-16